The 2010 Investment U Conference is underway! And even if you couldn't make it, now you can "bring home" more than 30 breakthrough presentations from the conference... Order the Deluxe MP3/Video Library for $99 to listen and view on your computer, or the Premier CD plus MP3/Video Library for $149 to listen to and view anywhere.
It’s been no secret that gold prices have been creeping up lately. At just over $900 per troy ounce, gold has run up over $90 in the past 16 days. And while we haven’t reached last year’s record price of $1002.80, moving over $900 is significant.
To put things in perspective, gold has only moved above $900 for a few brief periods historically – gold prices we’ve only seen in early 2008. If you’re looking at ways to invest at these prices, the SPDR Gold Trust ETF (NYSE: GLD) is an easy way to do it.
Option buying has been very bullish – traders still think the price has higher to go. And they may have something there. Gold does well in inflationary environments.
It’s no secret that the Fed has been flooding the markets with cash. And eventually all of that cash is going to cause inflation to creep up. The question is whether the price of gold has appreciated too much to be the inflation protection it needs to be?
Inflation has been ticking in at the lowest levels since 1954. Other than the influx of capital, there isn’t another major inflationary pressure out there. Food and fuel don’t seem to have it in them, and decreasing wages from an increasingly unemployed populace will continue to drive down prices.
Or, it could be that all of this inflation-speak is nothing more than a smokescreen for the fact that the United States and China haven’t been playing nicely. And the rush to gold has been in response to the world’s two largest economies slap-fighting over Yuan rates.
- Breaking Down the Disparity Between Oil and Gold Prices
- Inflation Hedging: Four Ways To Protect Your Investment Portfolio
- Gold Prices: Why You Shouldn’t Expect $1,000 Gold Anytime Soon
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed